Old Web
English
Sign In
Acemap
>
authorDetail
>
Johannes Voortman
Johannes Voortman
VU University Medical Center
Medicine
Immunology
Ovarian cancer
Cancer
Mesothelin
6
Papers
129
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma
2017
Clinical Genitourinary Cancer
Madelon Q. Wentink
Henk M.W. Verheul
Sumanta K. Pal
Saby George
Johannes Voortman
Pongwut Danchaivijitr
Remi Adelaiye
Diane Poslinski
Adrienne Groman
Alan D. Hutson
Roberto Pili
Show All
Source
Cite
Save
Citations (5)
Response and toxicity prediction by MALDI‐TOF‐MS serum peptide profiling in patients with non‐small cell lung cancer
2016
Proteomics Clinical Applications
Maria Rovithi
Joline S.W. Lind
Thang V. Pham
Johannes Voortman
Jaco C. Knol
Henk M.W. Verheul
Egbert F. Smit
Connie R. Jimenez
Show All
Source
Cite
Save
Citations (4)
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
2016
Molecular Cancer Therapeutics
Colin D. Weekes
Laetitia E. Lamberts
Mitesh J. Borad
Johannes Voortman
Robert R. McWilliams
Jennifer R. Diamond
Elisabeth G.E. de Vries
Henk M.W. Verheul
Christopher Hanyoung Lieu
George P. Kim
Yulei Wang
Suzie J. Scales
Divya Samineni
Flavia Brunstein
YounJeong Choi
Daniel J. Maslyar
Gerardo Colon-Otero
Show All
Source
Cite
Save
Citations (63)
1